0.89
-0.02(-2.21%)
Currency In USD
| Previous Close | 0.91 |
| Open | 0.91 |
| Day High | 0.92 |
| Day Low | 0.88 |
| 52-Week High | 1.61 |
| 52-Week Low | 0.71 |
| Volume | 92,521 |
| Average Volume | 169,329 |
| Market Cap | 55.58M |
| PE | -4.92 |
| EPS | -0.18 |
| Moving Average 50 Days | 0.96 |
| Moving Average 200 Days | 1.01 |
| Change | -0.02 |
If you invested $1000 in Cytosorbents Corporation (CTSO) 10 years ago, it would be worth $141.23 as of October 19, 2025 at a share price of $0.886. Whereas If you bought $1000 worth of Cytosorbents Corporation (CTSO) shares 5 years ago, it would be worth $103.08 as of October 19, 2025 at a share price of $0.886.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
CytoSorbents Postpones Earnings Release to Allow More Time to Complete Annual Audit Following the Passing of Corporate Controller
GlobeNewswire Inc.
Mar 04, 2025 12:00 PM GMT
The Company reaffirms previously provided preliminary financial results for the quarter and full year ended December 31, 2024, and continues to expect regulatory decisions on DrugSorb™-ATR marketing applications in 2025PRINCETON, N.J., March 04, 202
CytoSorbents to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
GlobeNewswire Inc.
Feb 26, 2025 12:00 PM GMT
PRINCETON, N.J., Feb. 26, 2025 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, will report fourth quarter
CytoSorbents Further Strengthens Balance Sheet with Exercise of Previously Announced Series A Right Warrants
GlobeNewswire Inc.
Feb 25, 2025 12:00 PM GMT
1,417,208 Series A Right Warrants Exercised at $1.13 Per Share, Providing $1.6 Million in Aggregate Gross ProceedsPRINCETON, N.J., Feb. 25, 2025 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threaten